Stefan Müller, currently Chief Financial Officer of Paul Hartmann AG and previously member of the Management Board of the ZEISS Industrial Quality & Research segment, will take on the position of Chief Financial Officer of Carl Zeiss AG starting 1 January 2024. OBERKOCHEN, Germany — The Supervisory Board of Carl Zeiss AG has appointed Stefan […]

Supports ambitious commercialisation strategy for DNA synthesis platform, gSynth Follows $10m Series A financing to scale operations   Cambridge, UK: Camena Bioscience, a synthetic biology company providing genes to the pharmaceutical and biotechnology industries, today announced it has appointed Dr Nicola Thompson as Chair of its Board of Directors. Following its $10 million Series A financing earlier in […]

Company names Paul Davy as CEO, appoints David Summa as Executive Chairman of the Board MENLO PARK, Calif.–Ionpath, a pioneer in high-plex spatial proteomics, today announced that Paul Davy, former Vice President of Customer Experience, has been appointed CEO of the company. Outgoing CEO David Summa is now Executive Chairman of Ionpath’s Board of Directors. […]

CAMBRIDGE, Mass. — Vizgen, the life science company dedicated to improving human health by visualizing single-cell spatial genomics information, today announced an expansion of its leadership team with the appointment of two highly accomplished industry leaders. The company has named Seth Benson, Chief Financial Officer, and Sara Mackey, Vice President Marketing. “We welcome Seth and Sara […]

Deepcell Hires Amirali Kia, Ph.D., as Vice President of Data Science and AI   MENLO PARK, Calif.– Deepcell, a pioneer in artificial intelligence (AI)-powered single cell analysis to fuel deep biological discoveries, today announced the appointment of Amirali Kia, Ph.D., as Vice President of Data Science and AI. In this position, Dr. Kia will join the […]

Ram Laxman brings executive leadership experience from 10x Genomics, Illumina, and Pacific Biosciences to expand BioSkryb’s international footprint DURHAM, N.C. –  BioSkryb Genomics, a company transforming single-cell analysis by enabling the most complete multiomic view of the cellular ecosystem, from discovery to diagnostics, has appointed Ram Laxman, Ph.D., as Chief Commercial Officer. Dr. Laxman will […]

RICHMOND, Va. — Grenova, Inc., a Virginia-based designer, manufacturer, and distributor of instruments and associated consumables for the life sciences industry, today announced the appointment of Todd Everline as Chief Financial Officer. Everline joins Grenova during a period of rapid growth as the company expands its award-winning team designed to make the life sciences industry […]

SAN DIEGO, CA – Element Biosciences, Inc., developer of the Element AVITI™ System, an innovative DNA sequencing platform that is disrupting the genomics industry, announced that William (Bill) P. Donnelly has joined its board of directors. Mr. Donnelly spent more than 20 years growing the international instrumentation firm Mettler-Toledo International Inc. and currently serves as lead independent director […]

FRANKLIN LAKES, N.J. — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that Ronald (Ron) Silverman, MD, FACS, has been named executive vice president and chief medical officer of BD, effective Dec. 4, 2023. Dr. Silverman will be responsible for leading the company’s Medical Affairs organization, which includes end-to-end medical […]

  SAN DIEGO —  ONI is delighted to announce the appointment of Dr. Alex Aravanis, MD, PhD, as the newest member of its esteemed board of directors. Dr. Aravanis brings a wealth of expertise and experience to the team, further strengthening ONI’s commitment to innovation and excellence. His impressive career includes notable positions such as […]